Pharmaceutical companies and surgeons take note!

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1650, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaceutical companies and research institutes are being called on by physicians

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 390, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manufacturer take heed

By Nicholson Susan Peterson Janet Yektashenas Behin

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 299-314

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical Care of Diabetes Patients—Let's Take Up the Challenge

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 17-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

What patients think about promotional activities of pharmaceutical companies in Turkey

By Semin Semih Güldal Dilek Özçakar Nilgün Mevsim Vildan

Pharmacy World and Science, Vol. 28, Iss. 4, 2006-08 ,pp. : 199-206

Springer Publishing Company

Access to resources Recommend Favorite

Merck versus Integra LifeSciences: A Victory for Pharmaceutical Companies

By Cassidy Kate Connelly Noreen

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 4, 2005-01 ,pp. : 207-208

Adis International

Access to resources Recommend Favorite